Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP MiP KENYA: DP vs SP for Malaria in Pregnancy
NCT01669941Phase 4Completed
- Sponsor
- Kenya Medical Research Institute
- Start
- Aug 2012
- Primary completion
- Oct 2014
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dihydroartemisinin + piperaquine in Plasmodium falciparum malaria, sponsored by Kenya Medical Research Institute. Started Aug 2012; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01669941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01669941.